Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
BMC Cancer|January 8, 2019
Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access programAxel Heidenreich, Silke Gillessen, Daniel Heinrich, et al.
Clinical Genitourinary Cancer|July 18, 2019
Disease Characteristics and Completion of Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223 in an International Early Access ProgramFred Saad, Silke Gillessen, Daniel Heinrich, et al.
Cancer|March 6, 2002
A novel somatostatin conjugate with a high affinity to all five somatostatin receptor subtypesUlrich Wulbrand, Martin Feldman, Andreas Pfestroff, et al.
Clinical Genitourinary Cancer|September 11, 2016
Hematologic Safety of Radium-223 Dichloride: Baseline Prognostic Factors Associated With Myelosuppression in the ALSYMPCA TrialNicholas J Vogelzang, Robert E Coleman, Jeff M Michalski, et al.
Anticancer Research|May 17, 2002
Development of dextran derivatives with cytotoxic effects in human urinary bladder cancer cell linesMarcela Marquez, Jin Du, Maliha Edgren, et al.
Oncotarget|April 7, 2015
Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxelPedram Kharaziha, Dimitris Chioureas, Dorothea Rutishauser, et al.
Acta Oncologica (Stockholm, Sweden)|October 6, 2007
Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost: a 6-year follow-upKarl Mikael Kälkner, Thomas Wahlgren, Marianne Ryberg, et al.
Oncotarget|September 30, 2015
Sorafenib-induced defective autophagy promotes cell death by necroptosisPedram Kharaziha, Dimitris Chioureas, George Baltatzis, et al.
The Lancet. Oncology|July 31, 2016
Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trialFred Saad, Joan Carles, Silke Gillessen, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|July 16, 2005
Prognostic and predictive factors in prostate cancer: historical perspectives and recent international consensus initiativesJohn R Srigley, Mahul Amin, Liliane Boccon-Gibod, et al.
Pageof 11